BridgeMD
New treatment option for Hematopoietic and Lymphoid System Neoplasm
Official title Provider-Mediated Communication of Genetic Testing Results to At-Risk Relatives of Cancer Patients to Improve Genetic Counseling and Testing Rates, Family HOPE Study
ClinicalTrials.gov ID: NCT05772130
What this study is testing
- What it's testing
- This clinical trial tests whether provider-mediated communication of genetic testing results to at-risk relatives of cancer patients can help improve genetic counseling and testing rates. Approximately 15% of people with cancer have an inherited form of cancer due to changes in a gene that they have inherited from one of their parents.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older. Healthy volunteers may be eligible.
You may be able to join if
- PATIENTS: Enrolled in City of Hope (COH) institutional review board (IRB) 07047 or have been seen by COH Genetics for genetic testing
- PATIENTS: Have an pathogenic/ likely pathogenic germline variant
- PATIENTS: Fluent in English
- PATIENTS: Age \>= 18 years
- PATIENTS: Willing to provide contact information for eligible first-degree relatives
You likely can't join if
- PATIENTS: Unable to provide informed consent
- PATIENTS: =\< 2 at-risk first-degree relatives who are eligible for genetic testing and/or reside within the United States
- PATIENTS: Unwilling to provide contact information for family members
- FIRST-DEGREE RELATIVES: Unable or unwilling to provide informed consent
- FIRST-DEGREE RELATIVES: Have undergone genetic testing for the known familial variant
- FIRST-DEGREE RELATIVES: Resides outside of the United States
See the full eligibility criteria
- PATIENTS: Enrolled in City of Hope (COH) institutional review board (IRB) 07047 or have been seen by COH Genetics for genetic testing
- PATIENTS: Have an pathogenic/ likely pathogenic germline variant
- PATIENTS: Fluent in English
- PATIENTS: Age \>= 18 years
- PATIENTS: Willing to provide contact information for eligible first-degree relatives
- PATIENTS: \>= 2 first-degree relatives that are eligible for genetic testing and reside in the United States of America
- FIRST-DEGREE RELATIVES: Proband is a COH patient and has consented to this study
- FIRST-DEGREE RELATIVES: First-degree relative of proband
- FIRST-DEGREE RELATIVES: Resides within the United States
- FIRST-DEGREE RELATIVES: Has not undergone genetic testing for the known familial variant
- FIRST-DEGREE RELATIVES: Are fluent in English
- FIRST-DEGREE RELATIVES: Age \>= 18 years
- PATIENTS: Unable to provide informed consent
- PATIENTS: =\< 2 at-risk first-degree relatives who are eligible for genetic testing and/or reside within the United States
- PATIENTS: Unwilling to provide contact information for family members
- FIRST-DEGREE RELATIVES: Unable or unwilling to provide informed consent
- FIRST-DEGREE RELATIVES: Have undergone genetic testing for the known familial variant
- FIRST-DEGREE RELATIVES: Resides outside of the United States
The study team makes the final eligibility decision.
Where it's taking place
- Duarte, California, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Duarte, California, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.